SERPINB4, serpin family B member 4, 6318

N. diseases: 64; N. variants: 0
Disease: Dermatitis, Atopic ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic 		0.050 Biomarker disease BEFREE Among the biomarkers tested, serum SCCA2 also showed the best correlations with clinical AD severity and TARC and showed the best diagnosability for AD in ROC analysis. 31378660 2019
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic 		0.050 AlteredExpression disease BEFREE Expression of SCCA2 in AD eruption was examined by immunohistochemistry. 28734739 2018
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic 		0.050 Biomarker disease BEFREE The findings show that SCCA2 is useful to aid diagnosis, estimate clinical severity and disease type, and assess responses to treatment in psoriasis and AD. 29642409 2018
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic 		0.050 Biomarker disease BEFREE Elevated levels of the serine protease inhibitors SERPINB3 and SERPINB4 are seen in patients with atopic dermatitis and psoriasis. 25111616 2015
CUI: C0011615
Disease: Dermatitis, Atopic
Dermatitis, Atopic 		0.050 Biomarker disease BEFREE We examined whether SCCA1 and SCCA2 could also serve as biomarkers of AD, reflecting its Th2-type immune responses, and whether the expression level of SCCA was correlated with clinical severity of AD. 16238792 2005